Reversal of Heparin Anticoagulation
Unfractionated Heparin (UFH) Reversal
Protamine sulfate is the definitive reversal agent for unfractionated heparin, administered as 1 mg protamine per 100 units of heparin given, with complete neutralization of anticoagulant effect. 1
Dosing Protocol for UFH Reversal
- Administer protamine sulfate by slow intravenous infusion at a dose of 1.0 to 1.3 mg per 100 units of heparin administered 2, 1
- No more than 50 mg should be given in any 10-minute period to minimize risk of adverse reactions 1
- The amount of protamine required decreases over time as heparin is metabolized; for dosing purposes, assume heparin has a half-life of approximately 30 minutes after IV injection 1
Monitoring and Confirmation
- Measure activated clotting time (ACT) or heparin level 5 to 10 minutes after protamine administration to confirm satisfactory reversal 2
- If residual heparin activity persists, additional protamine can be administered and reversal rechecked 2
- Recheck INR or ACT 30 minutes after protamine administration to assess degree of correction 3
Critical Safety Considerations
- Fatal anaphylactoid reactions have been reported with protamine; it should only be given when resuscitation techniques and treatment of anaphylactic shock are readily available 1
- Excess protamine itself induces a coagulopathy, so precise dosing is essential 2
- Anaphylactic reactions occur in approximately 3 per 100,000 doses via a non-IgE mechanism, possibly due to the solubilizer, and can result in cardiac arrest 2, 3
Low Molecular Weight Heparin (LMWH) Reversal
Protamine sulfate only partially reverses LMWH anticoagulation, neutralizing approximately 60% of anti-factor Xa activity, making it less effective than for UFH reversal. 2, 4
Dosing for LMWH Reversal
- Administer protamine sulfate intravenously for LMWH-associated bleeding, though complete reversal is not achievable 2
- The typical approach is 1 mg protamine per 100 anti-Xa units (or 1 mg enoxaparin) administered, though evidence for optimal dosing is limited 2
- For life-threatening bleeding on LMWH, administer protamine sulfate by slow IV infusion in addition to cessation of LMWH 2
Clinical Effectiveness Considerations
- Protamine reverses the anti-IIa (thrombin) activity of LMWH but has minimal effect on anti-Xa activity, which is the predominant mechanism of LMWH 2
- In clinical studies, bleeding stopped in approximately 67% (8 of 12) of actively bleeding patients treated with protamine for LMWH reversal 5
- Anti-Xa levels are useful to assess anticoagulation before protamine but unhelpful in monitoring its reversal effect 5
Important Limitations
- Protamine should primarily be used for UFH due to complete reversal; for LMWH, protamine provides only partial reversal and clinical effectiveness varies 2
- The American Society of Hematology notes that protamine administration for LMWH-associated life-threatening bleeding is conditionally recommended based on very low certainty evidence, with the possibility of benefit warranting its use 2
- Better reversal agents for LMWH are needed, as protamine's incomplete reversal leaves residual anticoagulant effect 5, 4
Clinical Algorithm for Heparin Reversal
For Active Major Bleeding on UFH:
- Stop heparin immediately
- Administer protamine sulfate 1 mg per 100 units of heparin given (maximum 50 mg per 10-minute period) 1
- Check ACT or heparin level at 5-10 minutes 2
- Repeat protamine if residual heparin activity persists 2
- Have resuscitation equipment immediately available due to anaphylaxis risk 1
For Active Major Bleeding on LMWH:
- Stop LMWH immediately
- Consider protamine sulfate administration (1 mg per 1 mg enoxaparin or 100 anti-Xa units), recognizing only partial reversal 2
- Provide supportive care with blood products as needed 2
- Monitor clinically for bleeding cessation rather than relying on anti-Xa levels 5
Common Pitfalls to Avoid:
- Do not exceed 50 mg protamine in any 10-minute period to prevent protamine-induced toxicity 1
- Do not expect complete LMWH reversal with protamine—only 60% of anti-Xa activity is neutralized 2, 4
- Do not administer protamine without immediate access to resuscitation equipment due to anaphylaxis risk 1
- Avoid excess protamine dosing, as it causes its own coagulopathy 2